onalespib (AT13387) / Otsuka  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
onalespib (AT13387) / Otsuka
NCT00878423: Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

Completed
1
62
US
AT13387
Astex Pharmaceuticals, Inc.
Metastatic Solid Tumors
05/13
03/14

Download Options